{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:15:09Z","timestamp":1793488509159,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR Collaborations for Leadership in Applied Health Research and Care West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice, also supports AAS","award":["NIHR-RP-2014-04-026"],"award-info":[{"award-number":["NIHR-RP-2014-04-026"]}]},{"name":"NHS Research and Infrastructure funds"},{"name":"NIHR Clinical Lectureship in General Practice"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1757-y","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T08:05:08Z","timestamp":1542701108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Comorbidities in polymyalgia rheumatica: a systematic review"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7362-0257","authenticated-orcid":false,"given":"Richard","family":"Partington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Helliwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyshah","family":"Abdul Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"1757_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0140-6736(97)05001-0","volume":"336","author":"CJ Michet","year":"2008","unstructured":"Michet CJ, Matteson EL. Polymyalgia rheumatica. Br Med J. 2008;336:765\u20139. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(97)05001-0\n                    \n                  .","journal-title":"Br Med J"},{"issue":"9634","key":"1757_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","volume":"372","author":"C Salvarani","year":"2008","unstructured":"Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372(9634):234\u201345. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(08)61077-6\n                    \n                  .","journal-title":"Lancet"},{"issue":"5","key":"1757_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","volume":"97","author":"TY Chuang","year":"1982","unstructured":"Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982;97(5):672\u201380.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1757_CR4","first-page":"205","volume":"5","author":"C Salvarani","year":"1987","unstructured":"Salvarani C, Macchioni PL, Tartoni PL, et al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol. 1987;5(3):205\u201315.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1757_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","volume":"49","author":"B Dasgupta","year":"2010","unstructured":"Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology. 2010;49(1):186\u201390. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kep303a\n                    \n                  .","journal-title":"Rheumatology"},{"issue":"3","key":"1757_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/2047487313514895","volume":"22","author":"L Clarson","year":"2013","unstructured":"Clarson L, Chandratre P, Hider S, et al. Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis. Eur J Prev Cardiol. 2013;22(3):335\u201343. \n                    https:\/\/doi.org\/10.1177\/2047487313514895\n                    \n                  .","journal-title":"Eur J Prev Cardiol"},{"issue":"9","key":"1757_CR7","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71(9):1524\u20139. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2011-200726\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1757_CR8","first-page":"2447","volume":"33","author":"\u00d6N Pamuk","year":"2006","unstructured":"Pamuk \u00d6N, \u00dcnl\u00fc E, \u00c7akir N. Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis. J Rheumatol. 2006;33(12):2447\u201352.","journal-title":"J Rheumatol"},{"issue":"12","key":"1757_CR9","first-page":"2597","volume":"28","author":"SW Jonsson","year":"2001","unstructured":"Jonsson SW, Backman C, Johnson O, et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol. 2001;28(12):2597\u2013602 pmid: 11764203.","journal-title":"J Rheumatol"},{"issue":"6","key":"1757_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/art.10269","volume":"46","author":"Y Kumeda","year":"2002","unstructured":"Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46(6):1489\u201397. \n                    https:\/\/doi.org\/10.1002\/art.10269\n                    \n                  .","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1757_CR11","first-page":"943","volume":"34","author":"PH Dessein","year":"2007","unstructured":"Dessein PH, Norton GR, Woodiwiss AJ, Joffe BI, Wolfe F. Influence of nonclassical cardiovascular-risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol. 2007;34(5):943\u201351.","journal-title":"J Rheumatol"},{"key":"1757_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1513\/pats.200703-045MS","volume":"4","author":"K Brown","year":"2007","unstructured":"Brown K. Rheumatoid lung disease. Proc Am Thorac Soc. 2007;4:443\u20138. \n                    https:\/\/doi.org\/10.1513\/pats.200703-045MS\n                    \n                  .","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"1757_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/art.30134","volume":"63","author":"Y-J Chen","year":"2011","unstructured":"Chen Y-J, Chang Y-T, Wang C-B, Wu C-Y. The risk of cancer in patients with rheumatoid arthritis: A nationwide cohort study in Taiwan. Arthritis Rheum. 2011;63(2):352\u20138. \n                    https:\/\/doi.org\/10.1002\/art.30134\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"1757_CR14","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","volume":"74","author":"C Dejaco","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P, et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015;74:1799\u2013807. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2015-207492\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"issue":"9836","key":"1757_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37\u201343. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(12)60240-2\n                    \n                  .","journal-title":"Lancet"},{"issue":"4","key":"1757_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1056\/NEJMra011913","volume":"347","author":"C Salvarani","year":"2002","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347(4):261\u201371.","journal-title":"N Engl J Med"},{"key":"1757_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","volume":"139","author":"CM Weyand","year":"2003","unstructured":"Weyand CM, Goronzy J. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med. 2003;139:505\u201316.","journal-title":"Ann Intern Med"},{"issue":"7","key":"1757_CR18","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"David Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement (reprinted from Annals of Internal Medicine). PLoS ONE. 2009;6(7):1-6. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1000097\n                    \n                  .","journal-title":"PLoS Medicine"},{"issue":"5","key":"1757_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0895-4356(93)90018-V","volume":"46","author":"T Byrt","year":"1993","unstructured":"Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol. 1993;46(5):423\u20139. \n                    https:\/\/doi.org\/10.1016\/0895-4356(93)90018-V\n                    \n                  .","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1757_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/art.34356","volume":"64","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Kremers HM, et al. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Arthritis Rheum. 2012;64(4):943\u201354. \n                    https:\/\/doi.org\/10.1002\/art.34356\n                    \n                  .","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1757_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.42.4.374","volume":"42","author":"AR Behn","year":"1983","unstructured":"Behn AR, Perera T, Myles AB. Polymyalgia rheumatica and corticosteroids: how much for how long? Ann Rheum Dis. 1983;42(4):374\u20138. \n                    https:\/\/doi.org\/10.1136\/ard.42.4.374\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1757_CR22","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/art.1780401022","volume":"40","author":"SE Gabriel","year":"1997","unstructured":"Gabriel SE, Sunku J, Salvarani C, O\u2019Fallon WM, Hunder GG. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum. 1997;40(10):1873\u20138. \n                    https:\/\/doi.org\/10.1002\/art.1780401022\n                    \n                  .","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1757_CR23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3899\/jrheum.110851","volume":"39","author":"M Mazzantini","year":"2012","unstructured":"Mazzantini M, Torre C, Miccoli M, et al. Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. J Rheumatol. 2012;39(3):552\u20137. \n                    https:\/\/doi.org\/10.3899\/jrheum.110851\n                    \n                  .","journal-title":"J Rheumatol"},{"issue":"5","key":"1757_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/art.11388","volume":"49","author":"A Proven","year":"2003","unstructured":"Proven A, Gabriel SE, Orces C, O\u2019Fallon WM, Hunder GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum. 2003;49(5):703\u20138. \n                    https:\/\/doi.org\/10.1002\/art.11388\n                    \n                  .","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1757_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-017-0987-1","volume":"16","author":"Z Paskins","year":"2018","unstructured":"Paskins Z, Whittle R, Sultan AA, et al. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study. BMC Med. 2018;16(4):1\u20139. \n                    https:\/\/doi.org\/10.1186\/s12916-017-0987-1\n                    \n                  .","journal-title":"BMC Med"},{"issue":"4","key":"1757_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/acr.23320","volume":"70","author":"I Shbeeb","year":"2018","unstructured":"Shbeeb I, Challah D, Raheel S, Crowson CS, Matteson EL. Comparable rates of glucocorticoid associated adverse events in patients with polymyalgia rheumatica and comorbidities in the general population. Arthritis Care Res. 2018;70(4):643\u20137. \n                    https:\/\/doi.org\/10.1002\/acr.23320\n                    \n                  .","journal-title":"Arthritis Care Res"},{"issue":"4","key":"1757_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00296-017-3874-3","volume":"38","author":"K Albrecht","year":"2018","unstructured":"Albrecht K, Huscher D, Buttgereit F, et al. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database. Rheumatol Int. 2018;38(4):569\u201377. \n                    https:\/\/doi.org\/10.1007\/s00296-017-3874-3\n                    \n                  .","journal-title":"Rheumatol Int"},{"key":"1757_CR28","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: \n                    http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm\n                    \n                  . Accessed 1 Nov 2016."},{"key":"1757_CR29","unstructured":"Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from \n                    http:\/\/handbook.cochrane.org\n                    \n                  ."},{"issue":"7","key":"1757_CR30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/art.1780240706","volume":"24","author":"BA Bengtsson","year":"1981","unstructured":"Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum. 1981;24(7):899\u2013904.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1757_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/rheumatology\/30.5.349","volume":"30","author":"P Bowness","year":"1991","unstructured":"Bowness P, Shotliff K, Middlemiss A, Myles AB. Prevalence of hypothyroidism in patients with polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol. 1991;30(5):349\u201351.","journal-title":"Br J Rheumatol"},{"issue":"8","key":"1757_CR32","first-page":"1335","volume":"20","author":"H Haga","year":"1993","unstructured":"Haga H, Eide G, Brun J, Johansen A, Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol. 1993;20(8):1335\u20139.","journal-title":"J Rheumatol"},{"issue":"7\u20138","key":"1757_CR33","first-page":"406","volume":"60","author":"H Juchet","year":"1993","unstructured":"Juchet H, Labarthe M, Ollier S, Vilain C, Arlet P. Prevalence of hypothyroidism and hyperthyroidism in patients with giant cell arteritis or polymyalgia rheumatica: a controlled study in one hundred and four cases. Rev du Rhum English Ed. 1993;60(7\u20138):406\u201311.","journal-title":"Rev du Rhum English Ed"},{"issue":"3","key":"1757_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/rheumatology\/34.3.261","volume":"34","author":"C Schaufelberger","year":"1995","unstructured":"Schaufelberger C, Bengtsson BA, Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol. 1995;34(3):261\u20134. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/34.3.261\n                    \n                  .","journal-title":"Br J Rheumatol"},{"issue":"11","key":"1757_CR35","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/rheumatology\/40.11.1238","volume":"40","author":"JT Gran","year":"2001","unstructured":"Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology. 2001;40(11):1238\u201342 \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11709607\n                    \n                  .","journal-title":"Rheumatology"},{"issue":"4","key":"1757_CR36","first-page":"737","volume":"29","author":"A Uddhammar","year":"2002","unstructured":"Uddhammar A, Eriksson A-L, Nystr\u00f6m L, et al. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol. 2002;29(4):737\u201342.","journal-title":"J Rheumatol"},{"issue":"10","key":"1757_CR37","first-page":"2143","volume":"29","author":"G Myklebust","year":"2002","unstructured":"Myklebust G, Wilsgaard T, Jacobsen BK, Gran TJ. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol. 2002;29(10):2143\u20137.","journal-title":"J Rheumatol"},{"issue":"8","key":"1757_CR38","first-page":"1694","volume":"29","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, O\u2019Fallon WM, Hunder GG, Gabriel SE. Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol. 2002;29(8):1694\u20137.","journal-title":"J Rheumatol"},{"issue":"1","key":"1757_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/03009740310000382","volume":"32","author":"G Myklebust","year":"2003","unstructured":"Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT. Causes of death in polymyalgia rheumatica. A prospective longitudinal study of 315 cases and matched population controls. Scand J Rheumatol. 2003;32(1):38\u201341. \n                    https:\/\/doi.org\/10.1080\/03009740310000382\n                    \n                  .","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"1757_CR40","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/art.21311","volume":"53","author":"HM Kremers","year":"2005","unstructured":"Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE. Direct medical costs of polymyalgia rheumatica. Arthritis Rheum. 2005;53(4):578\u201384. \n                    https:\/\/doi.org\/10.1002\/art.21311\n                    \n                  .","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1757_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","volume":"29","author":"WW Eaton","year":"2007","unstructured":"Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29(1):1\u20139.","journal-title":"J Autoimmun"},{"issue":"2","key":"1757_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/art.22548","volume":"57","author":"HMH Kremers","year":"2007","unstructured":"Kremers HMH, Reinalda MMS, Crowson CCS, Davis JMJ, Hunder GGG, Gabriel SES. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Care Res. 2007;57(2):279\u201386. \n                    https:\/\/doi.org\/10.1002\/art.22548\n                    \n                  .","journal-title":"Arthritis Care Res"},{"issue":"2","key":"1757_CR43","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1186\/ar2664","volume":"11","author":"KJ Warrington","year":"2009","unstructured":"Warrington KJ, Jarpa EP, Crowson CS, et al. Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study. Arthritis Res Ther. 2009;11(2):R50. \n                    https:\/\/doi.org\/10.1186\/ar2664\n                    \n                  .","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1757_CR44","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","volume":"163","author":"WW Eaton","year":"2006","unstructured":"Eaton WW, Byrne M, Ewald H, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006;163(3):521\u20138. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.163.3.521\n                    \n                  .","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1757_CR45","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/rheumatology\/keq040","volume":"49","author":"J Ji","year":"2010","unstructured":"Ji J, Liu X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden. Rheumatology. 2010;49(6):1158\u201363.","journal-title":"Rheumatology"},{"issue":"5","key":"1757_CR46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000332031","volume":"32","author":"J-H Kang","year":"2011","unstructured":"Kang J-H, Sheu J-J, Lin H-C. Polymyalgia rheumatica and the risk of stroke: a three-year follow-up study. Cerebrovasc Dis. 2011;32(5):497\u2013503. \n                    https:\/\/doi.org\/10.1159\/000332031\n                    \n                  .","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"1757_CR47","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/annonc\/mdr333","volume":"23","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Autoimmune disease and subsequent digestive tract cancer by histology. Ann Oncol. 2012;23(4):927\u201333. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdr333\n                    \n                  .","journal-title":"Ann Oncol"},{"key":"1757_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2377-12-41","volume":"12","author":"B Zoller","year":"2012","unstructured":"Zoller B, Li X, Sundquist J, Sundquist K. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol. 2012;12:41. \n                    https:\/\/doi.org\/10.1186\/1471-2377-12-41\n                    \n                  .","journal-title":"BMC Neurol"},{"issue":"1\u20134","key":"1757_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000333222","volume":"10","author":"X Li","year":"2012","unstructured":"Li X, Sundquist J, Sundquist K. Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden. Neurodegener Dis. 2012;10(1\u20134):277\u201384. \n                    https:\/\/doi.org\/10.1159\/000333222\n                    \n                  .","journal-title":"Neurodegener Dis"},{"issue":"8","key":"1757_CR50","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1093\/annonc\/mdr590","volume":"23","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Effect of autoimmune diseases on mortality and survival in subsequent digestive tract cancers. Ann Oncol. 2012;23(8):2179\u201384. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdr590\n                    \n                  .","journal-title":"Ann Oncol"},{"issue":"1","key":"1757_CR51","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ygyno.2012.07.100","volume":"127","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Ji J, Forsti A, Sundquist J, Sundquist K. Effect of autoimmune diseases on risk and survival in female cancers. Gynecol Oncol. 2012;127(1):180\u20135. \n                    https:\/\/doi.org\/10.1016\/j.ygyno.2012.07.100\n                    \n                  .","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1757_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0033442","volume":"7","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller B, Li X, Sundquist J, Sundquist K. Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One. 2012;7(3):1\u20138. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0033442\n                    \n                  .","journal-title":"PLoS One"},{"issue":"3","key":"1757_CR53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/07853890.2010.547515","volume":"44","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Li X, Sundquist J, Sundquist K. Risk of asthma and autoimmune diseases and related conditions in patients hospitalized for obesity. Ann Med. 2012;44(3):289\u201395.","journal-title":"Ann Med"},{"key":"1757_CR54","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1756-8722-5-59","volume":"5","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Forsti A, Ji J, Sundquist J, Sundquist K. Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma. J Hematol Oncol. 2012;5:59.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"1757_CR55","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/annonc\/mdu144","volume":"25","author":"M Fallah","year":"2014","unstructured":"Fallah M, Liu X, Ji J, Forsti A, Sundquist K, Hemminki K. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype. Ann Oncol. 2014;25(7):1397\u2013404. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdu144\n                    \n                  .","journal-title":"Ann Oncol"},{"key":"1757_CR56","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","volume":"25","author":"M Fallah","year":"2014","unstructured":"Fallah M, Liu X, Ji J, Forsti A, Sundquist K, Hemminki K. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol. 2014;25:2025\u201330. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdu365\n                    \n                  .","journal-title":"Ann Oncol"},{"key":"1757_CR57","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1136\/annrheumdis-2013-203465","volume":"73","author":"S Muller","year":"2014","unstructured":"Muller S, Hider SLS, Belcher J, Helliwell T, Mallen CD. Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database. Ann Rheum Dis. 2014;73:1769\u201373. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-203465\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"1757_CR58","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1503\/cmaj.140266","volume":"186","author":"AT Hancock","year":"2014","unstructured":"Hancock AT, Mallen CD, Muller S, et al. Risk of vascular events in patients with polymyalgia rheumatica. Can Med Assoc J. 2014;186(13):495\u2013501.","journal-title":"Can Med Assoc J"},{"key":"1757_CR59","doi-asserted-by":"publisher","unstructured":"Pfeifer EC, Crowson CS, Major BT, Matteson EL. Polymyalgia Rheumatica and its Association with Cancer. Rheumatology (Sunnyvale). 2015;(Suppl 6):003. \n                    https:\/\/doi.org\/10.4172\/2161-1149.S6-003.Polymyalgia\n                    \n                  .","DOI":"10.4172\/2161-1149.S6-003.Polymyalgia"},{"issue":"5","key":"1757_CR60","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/heartjnl-2015-308514","volume":"102","author":"M Pujades-Rodriguez","year":"2016","unstructured":"Pujades-Rodriguez M, Duyx B, Thomas SL, Stogiannis D, Smeeth L, Hemingway H. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases. Heart. 2016;102(5):383\u20139.","journal-title":"Heart"},{"issue":"5","key":"1757_CR61","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11739-017-1626-8","volume":"12","author":"Mattia Bellan","year":"2017","unstructured":"Bellan M, Boggio E, Sola D, et al. Association between rheumatic diseases and cancer: results from a clinical practice cohort study. Intern Emerg Med. 2017;12(5):621-7. \n                    https:\/\/doi.org\/10.1007\/s11739-017-1626-8\n                    \n                  .","journal-title":"Internal and Emergency Medicine"},{"issue":"12","key":"1757_CR62","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1136\/ard.2005.036459","volume":"64","author":"J Askling","year":"2005","unstructured":"Askling J, Klareskog L, Hjalgrim H, Baecklund E, Bjorkholm M, Ekbom A. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica\/giant cell arteritis. Ann Rheum Dis. 2005;64(12):1765\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1757_CR63","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","volume":"100","author":"LA Anderson","year":"2009","unstructured":"Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer. 2009;100(5):822\u20138.","journal-title":"Br J Cancer"},{"issue":"2","key":"1757_CR64","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ijc.24287","volume":"125","author":"LA Anderson","year":"2009","unstructured":"Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009;125(2):398\u2013405.","journal-title":"Int J Cancer"},{"issue":"1","key":"1757_CR65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/sj.bjc.6605733","volume":"103","author":"E Lanoy","year":"2010","unstructured":"Lanoy E, Engels EA. Skin cancers associated with autoimmune conditions among elderly adults. Br J Cancer. 2010;103(1):112\u20134.","journal-title":"Br J Cancer"},{"issue":"7","key":"1757_CR66","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3324\/haematol.2009.020412","volume":"95","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson SY, Landgren O, Samuelsson J, Bjorkholm M, Goldin LR. Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica. 2010;95(7):1216\u201320. \n                    https:\/\/doi.org\/10.3324\/haematol.2009.020412\n                    \n                  .","journal-title":"Haematologica"},{"key":"1757_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1756-8722-3-35","volume":"3","author":"LA Anderson","year":"2010","unstructured":"Anderson LA, Engels EA. Autoimmune conditions and hairy cell leukemia: an exploratory case-control study. J Hematol Oncol. 2010;3:35.","journal-title":"J Hematol Oncol"},{"issue":"24","key":"1757_CR68","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","volume":"118","author":"EK Lindqvist","year":"2011","unstructured":"Lindqvist EK, Goldin LR, Landgren O, et al. Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood. 2011;118(24):6284\u201391.","journal-title":"Blood"},{"key":"1757_CR69","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1192\/bjp.bp.111.092098","volume":"200","author":"SJ Chen","year":"2012","unstructured":"Chen SJ, Chao YL, Chen CY, et al. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry. 2012;200:374\u201380. \n                    https:\/\/doi.org\/10.1192\/bjp.bp.111.092098\n                    \n                  .","journal-title":"Br J Psychiatry"},{"issue":"9","key":"1757_CR70","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s10067-018-4137-8","volume":"37","author":"Rossana Scrivo","year":"2018","unstructured":"Scrivo R, Gerardi MC, Rutigliano I, et al. Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study. Clin Rheumatol. 2018;37(9):2573-7. \n                    https:\/\/doi.org\/10.1007\/s10067-018-4137-8\n                    \n                  .","journal-title":"Clinical Rheumatology"},{"key":"1757_CR71","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12891-016-1127-3","volume":"17","author":"M Yates","year":"2016","unstructured":"Yates M, Graham K, Watts R, MacGregor A. The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population. BMC Musculoskelet Disord. 2016;17:285.","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"1757_CR72","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/fampra\/cmn044","volume":"25","author":"K Barraclough","year":"2008","unstructured":"Barraclough K, Liddell WG, du Toit J, et al. Polymyalgia rheumatica in primary care: a cohort study of the diagnostic criteria and outcome. Fam Pract. 2008;25(5):328\u201333.","journal-title":"Fam Pract"},{"issue":"4","key":"1757_CR73","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/art.40017","volume":"69","author":"K Hellgren","year":"2017","unstructured":"Hellgren K, Baecklund E, Backlin C, Sundstrom C, Smedby KE, Askling J. Rheumatoid Arthritis and risk of malignant lymphoma: is the risk still increased? Arthritis Rheumatol. 2017;69(4):700\u20138. \n                    https:\/\/doi.org\/10.1002\/art.40017\n                    \n                  .","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1757_CR74","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/rmdopen-2018-000694","volume":"4","author":"A Floris","year":"2018","unstructured":"Floris A, Piga M, Cauli A, Salvarani C, Mathieu A. Polymyalgia rheumatica: zn autoinflammatory disorder? RMD Open. 2018;4(1):2\u20136. \n                    https:\/\/doi.org\/10.1136\/rmdopen-2018-000694\n                    \n                  .","journal-title":"RMD Open"},{"issue":"23","key":"1757_CR75","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1001\/jama.2011.822","volume":"305","author":"ER Haut","year":"2011","unstructured":"Haut ER, Pronovost PJ. Surveillance bias in outcomes reporting. JAMA. 2011;305(23):2462\u20133. \n                    https:\/\/doi.org\/10.1001\/jama.2011.822\n                    \n                  .","journal-title":"JAMA"},{"issue":"2","key":"1757_CR76","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.critrevonc.2008.01.013","volume":"67","author":"JF Piccirillo","year":"2008","unstructured":"Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW. The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol. 2008;67(2):124\u201332. \n                    https:\/\/doi.org\/10.1016\/j.critrevonc.2008.01.013\n                    \n                  .","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1757-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1757-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1757-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T20:21:26Z","timestamp":1574194886000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1757-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1757"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1757-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"29 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"258"}}